Hearing aids can seem like a big step. This NYC Ballet principal dancer doesn’t regret taking it
Many adults who could benefit from hearing aids don’t use them
another news portal
Many adults who could benefit from hearing aids don’t use them
Researchers found that cigarette smoke extract disrupted the lung cell barrier, increased IL-6 inflammation, and caused DNA damage in Calu-3 cells, while e-cigarette vapor extract
A national survey of 145 registered dietitians found wide variation in how the low FODMAP diet’s reintroduction phase is delivered, especially in dosing, timing, sequencing
This Nature Communications review argues that rat hepatitis E virus is an emerging zoonotic cause of hepatitis that is likely underdiagnosed because current tests are
Schools are being told to cut down on sugary desserts, and provide more vegetables and whole grains.
Former followers say the organisation is still putting lives at risk, despite a policy update.
In a repeated-measures study of 18 eumenorrheic female athletes, half-squat strength was highest in the late follicular phase and around ovulation, while handgrip strength peaked
Misinformation about contraception has been spreading on social media, alongside the “very real frustrations” of women complaining about side effects.
Stroke is one of the leading causes of death worldwide. Its recovery is often challenging as most of the stroke survivors remain chronically disabled, with
The share price of medical supplies titan Medline rose by 40% during Wednesday’s trading on the first day of its initial public offering.
U.S. health agencies led by Health and Human Services Secretary Robert F. Kennedy Jr., were beset by multiple controversies during 2025.
More than a quarter of people with Type 2 diabetes take GLP-1 receptor agonists, but the popular diabetes drugs might not work as well for
When in life we gain weight can have a significant impact on our health many years later. In a study involving over 600,000 people, researchers
Late breaking results from the phase III NRG GY019 trial indicate that letrozole monotherapy (L) did not demonstrate non inferiority to paclitaxel/carboplatin followed by letrozole